Sennosides

Manufacturer: Major Pharmaceuticals
Effective date: 2024-12-06
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: full-release
Hydrated at: 2026-06-01 00:41:10

Label at a glance#

ProductSennosides

Active ingredientSENNOSIDES

Label structure10 sections

Indications and uses

 relieves occasional constipation (irregularity)  generally produces a bowel movement in 6-12 hours

Dosage and administration

 take preferably at bedtime or as directed by a doctor age starting dosage maximum dosage adults and children 12 years of age and over 2 tablets once a day 4 tablets twice a day children 6 to under 12 years 1 tablet once a day 2 tablets twice a day children 2 to under 6 years 1/2 tablet once a day 1 tablet twice a day children under 2 years ask a doctor ask a doctor

Contacts and useful links#

PhonePoison Help1-800-222-1222

PhoneLabel contact1-800-616-2471

Label contents#

Full prescribing information#

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Active ingredient (in each tablet)
Sennosides 8.6 mg

OTC - PURPOSE SECTION

Purpose
Laxative

Uses

INDICATIONS & USAGE SECTION

 relieves occasional constipation (irregularity)
 generally produces a bowel movement in 6-12 hours

WARNINGS SECTION

OTC - DO NOT USE SECTION

 laxative products for longer than 1 week unless directed by a doctor

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have

 stomach pain

 nausea

 vomiting

 noticed a sudden change in bowel habits that continues over a period of 2 weeks

OTC - STOP USE SECTION

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

OVERDOSAGE SECTION

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

DOSAGE & ADMINISTRATION SECTION

 take preferably at bedtime or as directed by a doctor

age	starting dosage	maximum dosage
adults and children 12 years of age and over	2 tablets once a day	4 tablets twice a day
children 6 to under 12 years	1 tablet once a day	2 tablets twice a day
children 2 to under 6 years	1/2 tablet once a day	1 tablet twice a day
children under 2 years	ask a doctor	ask a doctor

Other information

OTHER SAFETY INFORMATION

 each tablet contains: calcium 20 mg.
 store in a dry place at 15° – 30°C (59° – 86°F).

INACTIVE INGREDIENT SECTION

croscarmellose sodium, dicalcium phosphate, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, mineral oil, polyethylene glycol, talc.

Questions or comments?

OTC - QUESTIONS SECTION

1-800-616-2471

SPL UNCLASSIFIED SECTION

TAMPER EVIDENT: DO NOT USE IF PRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.

Distributed by:
MAJOR® PHARMACEUTICALS
Indianapolis, IN 46268

*This product is not manufactured or distributed by Avrio Health L.P., owner of the registered trademark Senokot®.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Major

NDC 0904-7252-80

Compare to the active ingredient in Senokot® Tablets*

Senna Tablets

Sennosides

8.6 mg

Natural Vegetable Laxative Ingredient

1000 Tablets

Major Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
312935	sennosides 8.6 MG Oral Tablet	PSN	2
312935	sennosides, USP 8.6 MG Oral Tablet	SCD	2
312935	sennosides A and B 8.6 MG Oral Tablet	SY	2

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0904-7252-60	Sennosides	100 in 1 BOTTLE	TABLET, FILM COATED	100	2
0904-7252-61	Sennosides	10 in 1 BLISTER PACK	TABLET, FILM COATED	10	2
0904-7252-61	Sennosides	10 in 1 BOX, UNIT-DOSE	TABLET, FILM COATED	10	2
0904-7252-80	Sennosides	1000 in 1 BOTTLE	TABLET, FILM COATED	1000	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0904-7252	SENNOSIDES TABLET, FILM COATED [MAJOR PHARMACEUTICALS]	2	Current NDC, Legacy NDC, 4 package rows	20241208_df3b431b-a1ad-91dd-e053-2995a90aa02f.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0904-7252-60	EA - Each	0904-7252	8b411302-6cf8-4c67-887c-46174dec28f1	1	2023-03-13
0904-7252-61	EA - Each	0904-7252	4c7910a9-1558-4a7a-b204-d7064779beea	1	2023-04-07
0904-7252-80	EA - Each	0904-7252	70b43092-f10c-4350-9488-9b7bae9b8d25	1	2023-03-13

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

Sennosides
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
HYPROMELLOSES
TALC
MALTODEXTRIN
MICROCRYSTALLINE CELLULOSE
LIGHT MINERAL OIL
POLYETHYLENE GLYCOL 400
MAGNESIUM STEARATE
CROSCARMELLOSE SODIUM

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
0904-7252	0904-7252-60, 0904-7252-80, 0904-7252-61

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
DIBASIC CALCIUM PHOSPHATE DIHYDRATE	O7TSZ97GEP	IACT
HYPROMELLOSES	3NXW29V3WO	IACT
TALC	7SEV7J4R1U	IACT
MALTODEXTRIN	7CVR7L4A2D	IACT
MICROCRYSTALLINE CELLULOSE	OP1R32D61U	IACT
LIGHT MINERAL OIL	N6K5787QVP	IACT
POLYETHYLENE GLYCOL 400	B697894SGQ	IACT
SENNOSIDES	3FYP5M0IJX	ACTIB
MAGNESIUM STEARATE	70097M6I30	IACT
CROSCARMELLOSE SODIUM	M28OL1HH48	IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Sennosides	SENNOSIDES	Major Pharmaceuticals	df3b431b-a1ad-91dd-e053-2995a90aa02f	2024-12-06	Warnings	Exact identifier ndc (package): 0904-7252-61 ndc (package): 0904-7252-60 ndc (package): 0904-7252-80 ndc (product): 0904-7252 ndc11 (package): 00904725260 ndc11 (package): 00904725280 ndc11 (package): 00904725261 spl id: 289eb036-6a1f-4d89-e063-6394a90ac159 spl set id: df3b431b-a1ad-91dd-e053-2995a90aa02f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.